Anna Grimaldi

3.8k total citations · 2 hit papers
80 papers, 2.6k citations indexed

About

Anna Grimaldi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Anna Grimaldi has authored 80 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 19 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Anna Grimaldi's work include MicroRNA in disease regulation (11 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cancer-related molecular mechanisms research (6 papers). Anna Grimaldi is often cited by papers focused on MicroRNA in disease regulation (11 papers), Nanoparticle-Based Drug Delivery (7 papers) and Cancer-related molecular mechanisms research (6 papers). Anna Grimaldi collaborates with scholars based in Italy, United States and Czechia. Anna Grimaldi's co-authors include Michele Caraglia, Mariarosaria Incoronato, Silvia Zappavigna, Marco Salvatore, Gabriella Misso, Angela Lombardi, Peppino Mirabelli, Amalia Luce, Andrea Soricelli and Carlo Irace and has published in prestigious journals such as Chemical Reviews, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anna Grimaldi

76 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondria as playmakers of apoptosis, autophagy and senescence

2019 426 citations Angela Lombardi, Amalia Luce et al. profile →
Anti-Inflammatory Drugs as Anticancer Agents

2020 287 citations Silvia Zappavigna, Alessia Maria Cossu et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Anna Grimaldi

Since Specialization

Citations

This map shows the geographic impact of Anna Grimaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Grimaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Grimaldi more than expected).

Fields of papers citing papers by Anna Grimaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Grimaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Grimaldi. The network helps show where Anna Grimaldi may publish in the future.

Co-authorship network of co-authors of Anna Grimaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Grimaldi. A scholar is included among the top collaborators of Anna Grimaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Grimaldi. Anna Grimaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating miR-10b-5p, miR-193a-3p, and miR-1-3p Are Deregulated in Patients with Heart Failure and Correlate with Hormonal Deficiencies 2025 ·International Journal of Molecular Sciences ·Anna Grimaldi, Roberta D’Assante, (unknown), Simone Marcella, Stefania Paolillo, Francesco Cacciatore, Valentina Mercurio, Eduardo Bossone, Antonio Cittadini, Carlo G. Tocchetti, Mariarosaria Incoronato	1
2	Early phase development of PI3kinase inhibitors for anticancer therapies 2025 ·Expert Opinion on Investigational Drugs ·(unknown), Angela Lombardi, (unknown), (unknown), Raffaele Addeo, (unknown), Anna Grimaldi, Alois Nečas, Evžen Amler, Rossella Sperlongano, Michele Caraglia	0
3	Exploring thymic stromal lymphopoietin in the breast cancer microenvironment: A preliminary study 2025 ·Oncology Letters ·Simone Marcella, Mariantonia Braile, Anna Grimaldi, Andrea Soricelli, Giovanni Smaldone	1
4	An overview of Synlab SDN Biobank’s quality control system 2024 ·Scientific Reports ·Luigi Coppola, Anna Grimaldi, (unknown), (unknown), Giovanni Smaldone, Marco Salvatore	1
5	Peripheral blood BDNF and soluble CAM proteins as possible markers of prolonged disorders of consciousness: a pilot study 2024 ·Scientific Reports ·Luigi Coppola, (unknown), Anna Grimaldi, Anna Estraneo, Alfonso Magliacano, Andrea Soddu, Gregory Ciccarelli, Michael F. Salvatore, Carlo Cavaliere	4
6	“People are People”: Exploring Student-centred Design Thinking in the Co-creation of University Learning Experiences 2023 ·(unknown), Anna Grimaldi	1
7	Diagnostic and prognostic significance of extracellular vesicles in prostate cancer drug resistance: A systematic review of the literature 2022 ·Prostate Cancer and Prostatic Diseases ·Anna Grimaldi, Marco Salvatore, Carlo Cavaliere	7
8	Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 2020 ·Frontiers in Oncology ·Concetta Sciammarella, Amalia Luce, Ferdinando Riccardi, (unknown), Roberta Modica, Massimiliano Berretta, Gabriella Misso, Alessia Maria Cossu, Annamaria Colao, Giovanni Vitale, Alois Nečas, Ján Fedačko, Massimiliano Galdiero, Pierpaolo Correale, Antongiulio Faggiano, Michele Caraglia, Anna Capasso, Anna Grimaldi	13
9	Future perspectives of nanoparticle-based contrast agents for cardiac magnetic resonance in myocardial infarction 2019 ·Nanomedicine Nanotechnology Biology and Medicine ·Anna Grimaldi, Ernesto Forte, Teresa Infante, Carlo Cavaliere, Marco Salvatore, Filippo Cademartiri	10
10	DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes 2018 ·Contrast Media & Molecular Imaging ·Serena Monti, Marco Aiello, Mariarosaria Incoronato, Anna Grimaldi, (unknown), Peppino Mirabelli, Umberto Ferbo, Carlo Cavaliere, Marco Salvatore	41
11	Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study 2018 ·European Journal of Nuclear Medicine and Molecular Imaging ·Mariarosaria Incoronato, Anna Grimaldi, Carlo Cavaliere, Marianna Inglese, Peppino Mirabelli, Serena Monti, Umberto Ferbo, Emanuele Nicolai, Andrea Soricelli, Onofrio A. Catalano, Marco Aiello, Marco Salvatore	39
12	Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 2017 ·Nanomedicine Nanotechnology Biology and Medicine ·Enza Torino, Luigi Auletta, (unknown), Francesca Maria Orlandella, Giuliana Salvatore, Enrico Iaccino, (unknown), Anna Grimaldi, Annamaria Sandomenico, Sandra Albanese, Daniela Sarnataro, Matteo Gramanzini, Camillo Palmieri, Giuseppe Scala, Ileana Quinto, Paolo A. Netti, Marco Salvatore, Adelaide Greco	13
13	Pulmonary nocardiosis in Chronic Obstructive Pulmonary Disease: A new clinical challenge 2016 ·Respiratory Medicine Case Reports ·Giorgio Castellana, Anna Grimaldi, Marco Castellana, Claudio Farina, Giuseppe Castellana	17
14	Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 2016 ·Current Drug Targets ·Gabriella Misso, Mayra Rachele Zarone, Anna Grimaldi, Maria Teresa Di Martino, Angela Lombardi, Hiromichi Kawasaki, Paola Stiuso, Pierfrancesco Tassone, Pierosandro Tagliaferri, Michele Caraglia	15
15	In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma 2014 ·PLoS ONE ·Maria Teresa Di Martino, Virginia Campani, Gabriella Misso, Maria Eugenia Gallo Cantafio, Annamaria Gullà, Umberto Foresta, Pietro Hiram Guzzi, M. A. Castellano, Anna Grimaldi, Vincenzo Gigantino, Renato Franco, Sara Lusa, Mario Cannataro, Pierosandro Tagliaferri, Giuseppe De Rosa, Pierfrancesco Tassone, Michele Caraglia	93
16	Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC 2012 ·Journal of Cellular Physiology ·Gabriella Misso, G. Giuberti, Angela Lombardi, Anna Grimaldi, Filippo Ricciardiello, Antonio Giordano, Pierosandro Tagliaferri, Alberto Abbruzzese, Michele Caraglia	15
17	5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress 2012 ·Journal of Experimental & Clinical Cancer Research ·Monica Lamberti, Stefania Porto, Monica Marra, Silvia Zappavigna, Anna Grimaldi, (unknown), (unknown), Silvio Naviglio, Annamaria Spina, Nicola Sannolo, Michele Caraglia	107
18	Growth and endothelial differentiation of adipose stem cells on polycaprolactone 2011 ·Journal of Biomedical Materials Research Part A ·G. Marino, Francesco Rosso, Ferdinando Papale, Anna Grimaldi, (unknown), (unknown), Manlio Barbarisi, Alfonso Barbarisi	29
19	Charting out the octopus connectome at submicron resolution using the knife-edge scanning microscope 2010 ·BMC Neuroscience ·Yoonsuck Choe, Louise C. Abbott, Giovanna Ponte, John Keyser, Jaerock Kwon, David Mayerich, Daniel E. Miller, (unknown), Anna Grimaldi, Graziano Fiorito, David B. Edelman, Jeffrey L. McKinstry	6
20	Galactosyl derivative of N^ω‐nitro‐L‐arginine: Study of antiproliferative activity on human thyroid follicular carcinoma cells 2009 ·Journal of Cellular Physiology ·Daniela Melisi, Francesco Rosso, Annalisa Curcio, (unknown), Maria Nieddu, G. Marino, (unknown), Anna Grimaldi, (unknown), Simona Romano, Maria Fiammetta Romano, Gianpiero Boatto, Enrico Abignente, Alfonso Barbarisi, Maria Grazia Rimoli	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact